Regional Publications - 2024 Could Lentivirus Overcome the AAV Gene-Therapy. Challenges in Hemophilia A? Lentiviral Gene Therapy with CD34+ Hematopoietic Cells for Hemophilia A. Global prophylaxis trends in hemophilia: a macroeconomic analysis and its association with world development indicators.